ADAMTS13 and graft versus host disease: Our results demonstrate the role of VWF in T‐cell homing and the pathogenesis of GVHD, and the potential therapeutic benefit of interrupting T‐cell migration by administrating ADAMTS13 or recombinant VWF‐A2 peptide.